The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 05, 2019
Filed:
Apr. 07, 2017
Applicant:
Janssen Pharmaceutica NV, Beerse, BE;
Inventors:
Yin Liang, Ambler, PA (US);
Keith T. Demarest, Flemington, NJ (US);
Assignee:
Janssen Pharmaceutica NV, Beerse, BE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/00 (2006.01); A01N 43/00 (2006.01); A61K 31/381 (2006.01); A61K 31/7034 (2006.01); A61K 31/382 (2006.01); A61K 31/541 (2006.01); A61K 31/4436 (2006.01); A61K 31/397 (2006.01); A61K 31/444 (2006.01); A61K 31/4535 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/381 (2013.01); A61K 31/382 (2013.01); A61K 31/397 (2013.01); A61K 31/444 (2013.01); A61K 31/4436 (2013.01); A61K 31/4535 (2013.01); A61K 31/541 (2013.01); A61K 31/7034 (2013.01); A61K 45/06 (2013.01);
Abstract
Disclosed are compositions comprising (a) a GPR40 agonist and (b) an SGLT2 inhibitor, and methods for treating of disorders that are affected by the modulation of the GPR40 receptor and SGLT2 transporter. Such GPR40 compounds are represented by Formula (I) as follows: wherein ring W, R, R, R, R, R, A, and Z, are defined herein.